COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients

PURPOSE: Cancer patients are at high risk of developing severe illness from SARS-CoV-2 infection, but risk is lowered with receipt of COVID-19 vaccine. COVID-19 vaccination uptake among previously infected cancer patients may be influenced by an assumption of natural immunity, predicted weak immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Zainab, Patrick, Alicia L., Wallander, Michelle L., Donahue, Erin E., Trufan, Sally J., Tan, Antoinette R., Hwang, Jimmy J., Burgess, Earle F., Ragon, Brittany, Ghosh, Nilanjan, Grunwald, Michael R., Voorhees, Peter M., Copelan, Edward A., Raghavan, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060025/
https://www.ncbi.nlm.nih.gov/pubmed/37020982
http://dx.doi.org/10.1016/j.jvacx.2023.100289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060025/
https://www.ncbi.nlm.nih.gov/pubmed/37020982
http://dx.doi.org/10.1016/j.jvacx.2023.100289

Ejemplares similares